City

Ljubljana (1)

Peking (1)

Condition

Semaglutide (3)

Central Neural Response (1)

Fibrosis (1)

Gastric Emptying (1)

PCOS (1)

PCOS (Polycystic Ovary Syndrome) (1)

Scleroderma, Systemic (1)

Taste, Altered (1)

Tongue Tissue Transcriptome (1)

Overall Status

Not yet recruiting (2)

Completed (1)

Sign in for free

Phase

phase 4 (2)

phase 1 (1)

Sponsor

Peking University First Hospital (1)

Second Xiangya Hospital of Central South University (1)

University Medical Centre Ljubljana (1)

Collaborator

Intervention

calorie-restricted diet (1)

metformin hydrochloride 500 mg (1)

physical exercise (1)

placebo (1)

semaglutide (1)

semaglutide pen injector (1)

semaglutide, 1.34 mg/ml (1)

semaglutide, 1.34 mg/ml and metformin hydrochloride 500 mg (1)

Study Documents

Intervention Type

drug (3)

behavioral (1)

other (1)

Funder Type

Other (3)

Study Type

Interventional (3)

semaglutide

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Scleroderma, Systemic, Fibrosis, Semaglutide Trial (Semaglutide Pen Injector)

Not yet recruiting

Scleroderma, Systemic
+2 more

Semaglutide Pen Injector

(no location specified)

Nov 20, 2023

PCOS (Polycystic Ovary Syndrome), Semaglutide Trial in Peking (Metformin Hydrochloride 500 MG, Semaglutide, 1.34 mg/mL,

Not yet recruiting

PCOS (Polycystic Ovary Syndrome)
Semaglutide

Metformin Hydrochloride 500 MG
+4 more

Peking, Beijing, China

PekingUFH

Jan 18, 2023

PCOS, Semaglutide, Taste, Altered Trial in Ljubljana (Semaglutide, Placebo)

Completed

PCOS
+5 more

Semaglutide
Placebo

Ljubljana, Slovenia

UMC Ljubljana

Sep 28, 2021